Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study
Autor: | John P. Clancy, Agathe Ceppe, Jihong Wu, Timothy E. Corcoran, Pradeep Bhambhvani, Peter J. Mogayzel, Beth L. Laube, Scott D. Sagel, Felix Ratjen, Joseph M. Pilewski, Steven M. Rowe, William D. Bennett, Scott H. Donaldson |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Pulmonary and Respiratory Medicine Adult Male medicine.medical_specialty Adolescent Cystic Fibrosis Mucociliary clearance Sweat chloride Aminopyridines Cystic Fibrosis Transmembrane Conductance Regulator Lung Clearance Index Quinolones Aminophenols Cystic fibrosis Gastroenterology Article Ivacaftor Cohort Studies 03 medical and health sciences chemistry.chemical_compound Young Adult 0302 clinical medicine Internal medicine medicine Humans Benzodioxoles Longitudinal Studies Prospective Studies Child Chloride Channel Agonists Lung business.industry Lumacaftor respiratory system Middle Aged medicine.disease respiratory tract diseases Drug Combinations 030104 developmental biology medicine.anatomical_structure 030228 respiratory system chemistry Mucociliary Clearance Pediatrics Perinatology and Child Health Female business medicine.drug |
Zdroj: | J Cyst Fibros |
Popis: | CFTR function is required for normal mucociliary clearance (MCC) and cough-assisted clearance (CC). Lumacaftor-ivacaftor is approved for use in people with cystic fibrosis (CF) carrying two copies of F508del-CFTR. In this observational study performed at four study sites, we characterized the effect of lumacaftor-ivacaftor on mucociliary and cough clearance and related this to other clinical and research endpoints after one month of treatment. Twenty-five adolescents and adults were enrolled. No effect on whole lung MCC was observed, but CC was significantly increased. Sweat chloride improved by 18 mEq/L in this group, indicating a modest restoration of CFTR activity, but no demonstrable change in FEV1 or lung clearance index was observed. We speculate that the modest effect of lumacaftor-ivacaftor on CFTR function was insufficient to yield an improvement in MCC. |
Databáze: | OpenAIRE |
Externí odkaz: |